Bleximenib oxalate

(Synonyms: JNJ-75276617 oxalate; Menin-MLL inhibitor 24 oxalate)
2 Cited Publications
Kundenbewertung

Based on 2 publication(s) in Google Scholar

Bleximenib (JNJ-75276617) oxalate is an orally active and selective menin-KMT2A inhibitor, with IC50 values of 0.1 nM, 0.045 nM, and ≤0.066 nM for humans, mice, and dogs, respectively. Bleximenib oxalate can inhibit the proliferation and induce apoptosis and differentiation of tumor cells. Bleximenib oxalate can be used in the research of tumors such as leukemia.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

  • Reinheit: 98.97%
  • CAS. Nr.: 2866179-95-3
  • Formel: C34H52FN7O7
  • Molecular Weight:689.82
  • Speicherung:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 6 months , -20°C, 1 month
  • Biologische Aktivität
  • Chemical Information
  • Lösungsmittel & Löslichkeit
  • Reinheit & Dokumentation
  • Verweise
  • Help & FAQs
100 mg

Angebot einholen Auf Lager

Please select quantity
Amount: USD 0.00